Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FemPatch approval imminent in USA

April 19, 1996

FDA designates orphan drug for Peyronie's disease

April 19, 1996

Troglitazone NDA filing expected soon

April 19, 1996

RF-1051 cleared to enter phase II

April 19, 1996

Obesity gene identified

April 19, 1996

Warner-Lambert reports NPY1 antagonist

April 19, 1996

Warner-Lambert, Pfizer intend to copromote atorvastatin

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

ACAT inhibitor reported by Nisshin Flour Milling

April 19, 1996

Human Genome Sciences' research into cathepsin K

April 19, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...